CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 23 enrolled
Drug / intervention
Cord blood +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00305344
NCT00305344Phase 2Completed
CompareCT.gov

Transfusion of Autologous Umbilical Cord Blood to Reverse Hyperglycemia in Children With Type 1 Diabetes - A Pilot Study

University of Florida·interventional·Posted Mar 21, 2006·Updated Feb 9, 2022

In Brief

A Phase 2 clinical trial evaluating Autologous Umbilical Cord Blood Transfusion and Cord blood for Type 1 Diabetes Mellitus. Completed, enrolled 23 participants across 1 site.

Detailed Summary

While this study is now completely enrolled, we do hope to develop a "next generation" cord blood based study sometime in early 2009. Please continue to contact us if you have a child with newly diagnosed Type 1 Diabetes (T1D) who alo has their OWN cord blood in storage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
CollaboratorsJuvenile Diabetes Research Foundation, National Institutes of Health (NIH)

Timeline

Phase 2CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2006
Enrollment StartApr 1, 2005
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6.1 yearsPosted 20.3 years ago

Interventions

Autologous Umbilical Cord Blood Transfusionprocedure

Cord Blood infusion

Cord bloodbiological

Develop Cord blood vaccine